MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
about
Involvement and Clinical Aspects of MicroRNA in OsteosarcomaMicroRNAs and Potential Targets in Osteosarcoma: ReviewWhat Do We Know about the Role of miRNAs in Pediatric Sarcoma?Cell apoptosis, autophagy and necroptosis in osteosarcoma treatmentSerum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcomaStimulators of mineralization limit the invasive phenotype of human osteosarcoma cells by a mechanism involving impaired invadopodia formation.Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaA New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade.MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.Circulating microRNA profile in patients with membranous obstruction of the inferior vena cavamiR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.Expression of the Mir-133 and Bcl-2 could be affected by swimming training in the heart of ovariectomized ratsDifferentially expressed miRNAs in oxygen‑induced retinopathy newborn mouse modelsTargeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.microRNA and Bone Cancer.MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2.Translating microRNAs into biomarkers: What is new for pediatric cancer?MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9.Integrated bioinformatics analysis of miRNA expression in osteosarcoma.miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancerForkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcomamiR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1.miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma.MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma.MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy.Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion.Downregulation of lizard immuno-genes in the regenerating tail and myogenes in the scarring limb suggests that tail regeneration occurs in an immuno-privileged organ.Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130cas-mediated proliferation and migration of osteosarcoma cells.Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.
P2860
Q26748406-011F5B83-42BB-4B33-8AD2-65BFA6583A19Q26784033-70378F9E-390E-458A-828A-1E94EC52AB6FQ26800124-653CD8C9-5971-4A3E-9FC8-CC60B98D0BC5Q28067107-E3052114-5288-4904-B10C-2A3838AB6CD8Q34029191-F38AE7BB-632C-43A6-9C96-0DA05D6F3FF0Q34338502-D47D8486-01C2-48FE-B170-1B9F90A408BCQ35152173-B93E41DA-4706-4971-B9A0-A9B3043CF83BQ35557213-612A061A-865D-4A5B-9B9A-E9B68EB8EB42Q36261465-EE4ABDE4-6EF0-4F39-B1ED-769044872843Q36492647-F44B95C3-CDA0-4D63-A6C8-49231DC99721Q36639792-6C8DCAB7-DDA0-4A44-9C7C-79FA7863839FQ36742085-09A21CB3-20E0-4EF0-8ED6-BF0C9BC34E91Q36953173-E1403283-DBA3-41BC-8037-741BAD89ACFAQ37707599-6B6A78C3-12C9-438F-B7B1-BEC2CF24329DQ38585471-103FDA96-E25B-4F7C-A658-1896A985B100Q38667026-AFD951FA-7B24-44E7-93E3-064F6AEA8C08Q38700186-87044AC3-E2EC-4AB5-9893-5B00C05F1F70Q38810073-B7B05211-03DA-4054-8FA5-B29BDF4D7DCEQ38867232-69E42FE9-57BD-4E6D-89A2-60F5945FA772Q38957321-3191BEE2-7D0C-4656-9221-AD12A2FEF51EQ39674902-D6D1B16F-C487-4A72-847A-8E84E661B8BCQ41473012-DF6A9675-7545-4CE3-A9C4-551ABEC04AD8Q41623598-F7883DDB-AB3E-4BCB-832D-1AB8B6EEB81CQ41667363-DBDFEC85-AD22-410A-81A0-AEE9DB47B71BQ41856145-E437DEFA-9F68-4E3C-B075-D9276211E2D2Q41975973-989792B7-AD0C-42E1-9832-1CC27DCD1D2DQ42365381-AE8EDAEC-85DB-4B3A-97E5-F6C333F5449CQ42906390-7F4536D8-5DD4-4FFA-8F19-D46C95B9177DQ43131716-D75F4334-2E6E-4E60-BA03-684D4E5BD705Q43147650-1AF7A8B0-F60E-40A3-A04E-3213AD049E28Q44807317-01A342B5-359B-4719-8ECF-6CF2E619AC13Q47106247-61C4C343-B483-4901-BAE5-1DE8BE0016D4Q47750291-89143058-5C30-4871-90DA-D912F6D69B57Q49254629-5A1719FB-4FD2-4962-A263-3DDD444186FDQ49335068-AFBAA386-E770-40C6-BF54-27B9C106233FQ51081182-1C29B579-CF3C-48DD-961B-D3AE4ADB82D6Q51827995-E1591186-3FF4-460C-9732-769A8DD35717Q52669413-F0780413-4117-4864-B397-199CF40ECE15Q54976490-A108BE95-1133-4527-A9E7-B14275D2165AQ54981639-E99AE4E5-0ED8-4DEC-BD89-D07959E73630
P2860
MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@ast
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@en
type
label
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@ast
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@en
prefLabel
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@ast
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@en
P2093
P2860
P1433
P1476
MiR-133b is down-regulated in ...... asion, and promotes apoptosis.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0083571
P407
P577
2013-12-31T00:00:00Z